Esperion to cut work force 40%

ANN ARBOR—Esperion Therapeutics Inc. (Nasdaq: ESPR), developers of a new class of cholesterol-lowering drugs, announced a 40 percent work force reduction and said it would focus its marketing efforts more …

Alerje wins federal grant

DETROIT–The National Science Foundation has awarded a federal grant to Alerje, the Detroit-based startup developing digital tools for food allergy management, under the Small Business Innovation Research program of the …